An international team with involvement of ICMAB and IMB-CNM researchers develops a medical device capable of monitoring heart failure from saliva samples.The instrument contains a biosensor chip which teams up with functionalized magnetic nanoparticles in order to detect heart failure-related biomarkers found in saliva.The device, developed in the framework of the European project KardiaTool, can be […]
Mycoplasma genitalium’s Cell Adhesion Mechanism Revealed 30.01.2019Mycoplasma genitalium is a sexually transmitted bacterium responsible for several genitourinary disorders. An estimated 1% of the adult population is infected with this bacterium. The discovery opens the door to defining new therapeutic strategies to fight this pathogen which is becoming more and more resistant to current antibiotics. The discovery Researchers from the Molecular Biology […]
MRS7145: First photoactive drug to fight Parkinson’s 11.01.2019An international team of researchers designs a photoactive drug for the treatment of Parkinson’s diseaseThe developed photoactive drug, MRS7145, proves effective in animal modelsThe novel therapeutic development could be the foundation for new therapies against Parkinson’s disease Parkinson’s disease and a few pharmacological considerations Parkinson’s is the second most common neurodegenerative disease after Alzheimer’s, affecting […]
New AI-based method to diagnose breast cancer 30.04.2018A new artificial intelligence-based method to diagnose breast cancer is developed in an international partnership featuring IFIC A team of researchers from the Instituto de Física Corpuscular (IFIC), has participated in the development of a system to help in the diagnosis of breast cancer. The development, which will be of great help in clinical practice, […]
On the protective effects of Alzheimer’s on Cancer 23.04.2018A study published in the journal Scientific Reports studies the comorbility relations between these two diseases. Patients with Alzheimer’s disease have a higher risk of developing glioblastoma and a lower risk of lung cancer. A paper published in Scientific Reports by researchers from the Spanish National Cancer Research Centre (CNIO), headed by Alfonso Valencia, a […]
New DNA error repair machinery – opening prospects in biomedicine and industry 09.04.2018An article published in Nature Communications shows that some microorganisms have a hitherto unknown system for detection and correction of errors in the genetic material. This mechanism prevents some bacteria, such as Mycobacterium tuberculosis, from easily developing resistance to antibiotics. This research opens the door to the development of new strategies to combat antibiotic resistance […]
The biotechnology company ZeClinics receives a grant of €1.87M from the European Commission 10.02.2018A grant awarded to ZeClininics allows it to develop and accelerate the commercialization of one of its flagship products: ZeCardio®, a predictive system for the analysis of the cardiovascular effects of drugs during the discovery phase. One of the most important challenges for biotech companies is to get enough funding to turn their most innovative […]